Effect of Shoulder Symptom Modification Procedure (SSMP) in Managing Patients with Frozen Shoulder
Launched by GULF MEDICAL UNIVERSITY · Jan 7, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different treatments can help people with frozen shoulder, a condition that causes pain and limits movement in the shoulder. The main goal is to see which treatment—Shoulder Symptom Modification Procedure (SSMP), Mobilization with Movement (MWM), or a sham (fake) treatment—works best to reduce pain and improve shoulder function. The trial is currently looking for participants aged 40 to 65 who have been diagnosed with this condition and have difficulty moving their shoulder.
To be eligible for the trial, participants need to have a specific diagnosis of frozen shoulder and show significant pain and limited movement. Those with a history of shoulder dislocation, fractures, cancer, or heart disease cannot join the study. If you participate, you will receive one of the treatments and will be monitored to see how well it helps with your shoulder symptoms. Your involvement could contribute to finding better ways to manage this frustrating condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Diagnosis of adhesive capsulitis confirmed by a healthcare professional.
- • Scores more than 2 in adhesive capsulitis scale
- • Range of motion affected in capsular pattern
- • Age between 40-65 years.
- • Willingness to participate by signing informed consent
- Exclusion Criteria:
- • Having any history of shoulder dislocation
- • Humerus fractures or trauma
- • Diagnosed with any sort of cancer
- • History of cardiovascular disease
About Gulf Medical University
Gulf Medical University (GMU) is a prestigious academic institution located in the United Arab Emirates, dedicated to advancing healthcare through innovative education and research. As a leading clinical trial sponsor, GMU focuses on enhancing medical knowledge and improving patient outcomes by conducting rigorous and ethically sound clinical studies. The university fosters collaborations with local and international healthcare organizations, ensuring adherence to the highest standards of clinical research. With a commitment to excellence in medical education and research, GMU plays a pivotal role in the development and evaluation of new therapeutic interventions and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ajman, , United Arab Emirates
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported